Growth Metrics

Novartis Ag (NVS) Profit After Tax Growth (5y) (2014 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2025 -6.40%
Jun 30, 2024 9.01%
Dec 31, 2023 56.90%
Jun 30, 2023 -21.41%
Mar 31, 2023 -3.71%
Dec 31, 2022 50.14%
Sep 30, 2022 -0.14%
Jun 30, 2022 20.79%
Mar 31, 2022 2.61%
Dec 31, 2021 39.55%
Sep 30, 2021 3.99%
Jun 30, 2021 60.61%
Mar 31, 2021 22.68%
Dec 31, 2020 60.95%
Sep 30, 2020 31.43%
Mar 31, 2020 1,201.75%
Mar 31, 2019 1,475.53%
Sep 30, 2017 1,512.77%
Jun 30, 2017 1,910.80%
Mar 31, 2017 1,482.48%
Dec 31, 2016 1,464.38%
Sep 30, 2016 1,478.37%
Jun 30, 2016 1,484.33%
Mar 31, 2016 1,110.09%
Dec 31, 2015 -30.25%
Sep 30, 2015 1,100.35%
Mar 31, 2015 -29.35%
Dec 31, 2014 -95.26%
Sep 30, 2014 -23.24%
Mar 31, 2014 -23.60%